The new deeming regulations from the U.S. Food and Drug Administration (FDA) will limit the regulatory authority of states and localities in a wide range of areas, with e-cigarette labelling proving to be one of the most contentious.
Submit your access request to explore how it streamlines access to critical market and regulatory insights
"*" indicates required fields